v3.26.1
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Income Tax Disclosure [Abstract]    
Net operating loss carryforwards $ 1,839,826 $ 1,592,349
Directors fees 91,161
Fixed assets 426 650
Patents 21,385 24,468
R&D expenses 137,753 122,114
Total deferred tax assets 2,090,551 1,739,581
Less: valuation allowance (2,090,551) (1,739,581)
Net deferred tax asset